The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer.
Abu-Khalaf
Maysa M
MM
Medical and Gynecologic Oncology, Yale Comprehensive Cancer Center, New Haven, CT, USA.
Harris
Lyndsay
L
D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood* / Q000378:metabolism / Q000401:mortality*; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D011237:Predictive Value of Tests; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000097:blood* / Q000737:chemistry*; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases